Medicare may soon cover GLP-1 weight-loss drugs under a new CMS program, allowing eligible beneficiaries to pay as little as $50 a month.

Some parents will choose to spring for the GLP-1 meds, even if it means raiding the college fund. Another option is bariatric surgery, also not ideal.

This blog has pointed out many of the societal costs of obesity, so for the end of December, it gathers a little bouquet of talking points.

FDA approves the first Wegovy weight loss pill, offering an oral GLP-1 alternative with results similar to injections.

According to at least one theory, all the behaviors that combine to define an eating disorder are just maladaptive coping strategies.

Although styles of therapy differ, it is widely accepted that the root of all psychological malfunction is pain.

New research reveals how gut microbes send metabolites to the liver and heart, shaping insulin sensitivity and metabolism linked to obesity and type 2 diabetes.

It seems unfair that even people who grow enough to accept and follow advice will still mess up so badly in choosing which advice to adopt.

How often does it happen that a perfectly valid therapeutic approach fails, although there may be nothing wrong with that approach whatsoever?

Learn why lifestyle changes and tools like BrainWeighve are essential for lasting weight-loss success.

There seems to be a “Just say no to emotional pain” school of thought that tends not to work out well in everyday life.

Apparently, the basic goal of Internal Family Systems is to rope all those confused yet earnestly striving inner beings onto the “same page.”

WHO issues its first guideline on GLP-1 weight-loss drugs, offering conditional recommendations on long-term use, access, safety, and global obesity treatment.

Why do some experts consider Internal Family Systems (IFS) an unsafe form of psychotherapy?

A global review of 177 studies reveals key early-life factors driving childhood obesity, highlighting risks, research gaps, and opportunities for prevention.

Poet Walt Whitman famously said, “I contain multitudes.” But is that true of everyone?

The object of IFS is to provide not just symptom management, but actual deep healing.

GLP-1 drug prices drop 30% as new research shows benefits for youth with type 2 diabetes amid rising childhood hypertension rates.

We return to the previously mentioned controversial figure of Richard C. Schwartz, who formulated and practiced Internal Family Systems.

GLP-1 drugs are reshaping diabetes and weight-loss care. Here’s how new treatments, pricing shifts, and coverage decisions impact employer health plans.

We highlight why many parents hope that their children will not become obese, and how some parents want to do everything possible to keep this from happening.

When it comes to kids and GLP-1s, careful consideration is just as vital as clinical innovation.

Children are much more likely to imitate what they see at home every day than to follow precepts that are taught in any other way.

In the USA and the world, the emphasis on childhood obesity is a vital part of the overall health picture. Why?

Penn State researchers are using AI to track how quickly kids eat — a key factor linked to childhood obesity risk.

Here’s how obesity is always doing its best to cheat a person of the full enjoyment of life in all its aspects.

Learn how evidence-based treatments like semaglutide, tirzepatide, and GLP-1 receptor agonists are reshaping adult and pediatric obesity care.

Learn expert insights from AAP 2025 on pediatric obesity management — whole-child care, treatment choices, access barriers, and reducing stigma.

Childhood obesity will ultimately cost someone a significant amount of money, whether it be the parents or the kids themselves when they grow up.

Most people probably do not have a clue about all the history behind the availability (or not) of water in either public locales or in places of business.